8-K: Current report filing
Published on February 13, 1998
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) January 10, 1998
--------------------------
COMMONWEALTH BIOTECHNOLOGIES, INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
911 East Leigh Street, Suite G-19, Richmond, Virginia 23219
---------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (804) 648-3820
------------------------
N/A
-----------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 5. Other Events.
On January 10, 1998, the Registrant issued a press release detailing
the Registrant's earnings for the 1997 fiscal year. Such press release is
included as an exhibit to this Current Report on Form 8-K.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release, dated January 10, 1998,
announcing the Registrant's earnings for the 1997
fiscal year.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COMMONWEALTH BIOTECHNOLOGIES, INC.
By: /s/ Robert B. Harris, Ph.D.
-------------------------------
Robert B. Harris, Ph.D.
President
January 11, 1998
3
EXHIBIT INDEX
Number Description of Exhibit
- ------ ----------------------
99.1 Press Release, dated January 10, 1998.